PersonAuto-indexed · Unverified
Andrew Levin
Boston, US· Director
Named on 8 public capital-raising filings across 7 companies. Compiled automatically from public SEC filings — not verified by this individual.
Companies
Filings (8)
Climb Bio, Inc. raised $110.1M
Climb Bio, Inc.· Director· May 4, 2026
Slate Medicines, Inc. raised $10.0M
Slate Medicines, Inc.· Director· Mar 11, 2026
Solstice Oncology, Inc. raised $121.3M
Solstice Oncology, Inc.· Director· Mar 9, 2026
Lonestar Medicines, Inc. raised $25.0M
Lonestar Medicines, Inc.· Director· Feb 23, 2026
Imbria Pharmaceuticals, Inc. raised $66.7M
Imbria Pharmaceuticals, Inc.· Director· Dec 16, 2025
Superluminal Medicines, Inc. raised $5.0M
Superluminal Medicines, Inc.· Director· Aug 26, 2025
Pahr Therapeutics, Inc. raised $4.7M
Pahr Therapeutics, Inc.· Director· Jul 18, 2025
Imbria Pharmaceuticals, Inc. raised $59.2M
Imbria Pharmaceuticals, Inc.· Director· Apr 1, 2025